BALA CYNWYD, PA – January 12, 2004 – Prominent Philadelphia-area facial plastic and reconstructive surgeon specialist Dr. Timothy M. Greco, M.D., F.A.C.S. has been certified as a faculty trainer and regional media spokesperson for the cosmetic filler product Restylane. The FDA approved Restylane on December 13, 2003.
Restylane is the first and only FDA approved biodegradable dermal filler used by physicians for the correction of moderate to severe facial wrinkles and folds of the face. The product NASHA or Non-Animal Stabilized Hyaluronic Acid is the purest form of hyaluronic acid in the world. The Restylane treatment is a simple, convenient procedure adding volume in two ways: first the gel lifts the skin, and then hyaluronic acid attracts and binds water molecules which add more volume. Treatment results are visible immediately.
Restylane is longer-lasting than other filler products, like Collagen, and provides noticeable results for 6 to 9 months. Restylane also has a decade long track record for being safe, effective and trusted by physicians and patients in over 60 countries.
The Restylane procedure is simple and fast, requiring only brief injections to the target areas, which is why Restylane has been referred to by the media as "the lunchtime facelift."
Dr. Greco recently was featured on Philadelphia's NBC affiliate TV-10's 10! Show where he injected two patients with Restylane and demonstrated the immediate results. Also, in the December 2003 issue of MainLine Today, Dr. Greco was named by his peers as one of the top four facial plastic surgeons in the Greater Philadelphia area. In the February 2003 issue of Philadelphia Magazine Dr. Timothy Greco was recognized as a "Top Plastic Surgeon" in the Delaware Valley as voted by plastic surgeons, dermatologists and other aesthetic specialists.Back To Top